Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, parallel, open-label, multicenter, phase IV clinical trial to
assess the efficacy and safety of pregabalin and alpha-lipoic acid combination compared with
each monotherapy in patients with diabetic peripheral neuropathy for 12 weeks.